Jim Frates directs the Finance and Corporate Communications departments at Alkermes. During his tenure, Alkermes has raised substantial public capital and acquired the pulmonary drug delivery company, Advanced Inhalation Research, Inc. (AIRŪ). Jim was previously a Vice President in charge of the East Coast Life Sciences Practice at Robertson Stephens & Company, Inc. He has also worked in health care investment banking at Morgan Stanley & Company, Inc. and spent a year teaching secondary school at the Royal Shrewsbury School in the U.K., as the Harvard College Fellow. Jim currently serves as Audit Committee Chairman on the Board of Directors of GPC Biotech of Germany and serves as a national chairperson of the Association of Bioscience Financial Officers. Jim received a B.A. in Government from Harvard College and an M.B.A. from the Harvard Graduate School of Business Administration.